PCS-2023 > 3 > 3E > 3E0 > 3E0G |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0G | Introduction, Upper GI | |
3E0G3 | Percutaneous | |
3E0G30 | Antineoplastic | |
3E0G304 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Percutaneous Approach | |
3E0G305 | Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach | |
3E0G30M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach | |
3E0G32 | Anti-infective | |
3E0G328 | Introduction of Oxazolidinones into Upper GI, Percutaneous Approach | |
3E0G329 | Introduction of Other Anti-infective into Upper GI, Percutaneous Approach | |
3E0G33 | Anti-inflammatory | |
3E0G33Z | Introduction of Anti-inflammatory into Upper GI, Percutaneous Approach | |
3E0G36 | Nutritional Substance | |
3E0G36Z | Introduction of Nutritional Substance into Upper GI, Percutaneous Approach | |
3E0G37 | Electrolytic and Water Balance Substance | |
3E0G37Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Percutaneous Approach | |
3E0G3B | Anesthetic Agent | |
3E0G3BZ | Introduction of Anesthetic Agent into Upper GI, Percutaneous Approach | |
3E0G3H | Radioactive Substance | |
3E0G3HZ | Introduction of Radioactive Substance into Upper GI, Percutaneous Approach | |
3E0G3K | Other Diagnostic Substance | |
3E0G3KZ | Introduction of Other Diagnostic Substance into Upper GI, Percutaneous Approach | |
3E0G3N | Analgesics, Hypnotics, Sedatives | |
3E0G3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Percutaneous Approach | |
3E0G3T | Destructive Agent | |
3E0G3TZ | Introduction of Destructive Agent into Upper GI, Percutaneous Approach | |
3E0G3G | Other Therapeutic Substance | |
3E0G3GC | Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach | |
3E0G3S | Gas | |
3E0G3SF | Introduction of Other Gas into Upper GI, Percutaneous Approach | |
3E0G7 | Via Natural or Artificial Opening | |
3E0G70 | Antineoplastic | |
3E0G704 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening | |
3E0G705 | Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening | |
3E0G70M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening | |
3E0G72 | Anti-infective | |
3E0G728 | Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening | |
3E0G729 | Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening | |
3E0G73 | Anti-inflammatory | |
3E0G73Z | Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening | |
3E0G76 | Nutritional Substance | |
3E0G76Z | Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening | |
3E0G77 | Electrolytic and Water Balance Substance | |
3E0G77Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening | |
3E0G7B | Anesthetic Agent | |
3E0G7BZ | Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening | |
3E0G7H | Radioactive Substance | |
3E0G7HZ | Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening | |
3E0G7K | Other Diagnostic Substance | |
3E0G7KZ | Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening | |
3E0G7N | Analgesics, Hypnotics, Sedatives | |
3E0G7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening | |
3E0G7T | Destructive Agent | |
3E0G7TZ | Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening | |
3E0G7G | Other Therapeutic Substance | |
3E0G7GC | Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening | |
3E0G7S | Gas | |
3E0G7SF | Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening | |
3E0G8 | Via Natural or Artificial Opening Endoscopic | |
3E0G80 | Antineoplastic | |
3E0G804 | Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G805 | Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G80M | Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G82 | Anti-infective | |
3E0G828 | Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G829 | Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G83 | Anti-inflammatory | |
3E0G83Z | Introduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G86 | Nutritional Substance | |
3E0G86Z | Introduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G87 | Electrolytic and Water Balance Substance | |
3E0G87Z | Introduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8B | Anesthetic Agent | |
3E0G8BZ | Introduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8H | Radioactive Substance | |
3E0G8HZ | Introduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8K | Other Diagnostic Substance | |
3E0G8KZ | Introduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8N | Analgesics, Hypnotics, Sedatives | |
3E0G8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8T | Destructive Agent | |
3E0G8TZ | Introduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8G | Other Therapeutic Substance | |
3E0G8GC | Introduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G8S | Gas | |
3E0G8SF | Introduction of Other Gas into Upper GI, Via Natural or Artificial Opening Endoscopic | |
3E0G4 | Percutaneous Endoscopic | |
3E0G4G | Other Therapeutic Substance | |
3E0G4GC | Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Endoscopic Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |